Laser-induced breakdown spectroscopy emerges as fast, cost-efficient method for biomass analysis

NewsGuard 100/100 Score

Laser-induced breakdown spectroscopy (LIBS) is emerging as a fast, cost-efficient method for identifying the total amount and specific compounds that comprise the inorganic component of biomass. Accurate and reliable analysis of these minerals, such as aluminum, calcium, iron, and silicon is essential, as this "ash" can cause problems when converting biomass to hydrocarbon biofuels, as described in a study published in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available to download for free on the Industrial Biotechnology website.

In "Rapid Analysis of Inorganic Species in Herbaceous Materials Using Laser-Induced Breakdown Spectroscopy", Tyler Westover and Rachel Emerson, Idaho National Laboratory (Idaho Falls), compare the results obtained from analyzing 12 samples using LIBS to the results from three common ash-analysis methods that reply on inductively coupled plasma-optical emission spectrometry/mass spectrometry (ICP-OES/MS). Analysis for nine inorganic elements showed the accuracy of LIBS to be comparable to that of ICP-OES methods, with concentrations measured to an uncertainty of about 100 parts per million. The researchers identify several key benefits of LIBS, including its low cost, rapid turnaround time, lack of reagent consumption, and minimal sample preparation.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy